Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The immune checkpoint inhibitors: where are we now?

× No keyword cloud information.

47 in total

Review 1. Targeting memory T cells in type 1 diabetes.

Authors: Mario R Ehlers; Mark R Rigby
Journal: Curr Diab Rep Date: 2015-11 Impact factor: 4.810

2. Deal watch: Genentech dives deeper into the next wave of cancer immunotherapies.

Authors: Sarah Crunkhorn
Journal: Nat Rev Drug Discov Date: 2014-12 Impact factor: 84.694

Review 3. Cardiovascular toxicities associated with immune checkpoint inhibitors.

Authors: Jiun-Ruey Hu; Roberta Florido; Evan J Lipson; Jarushka Naidoo; Reza Ardehali; Carlo G Tocchetti; Alexander R Lyon; Robert F Padera; Douglas B Johnson; Javid Moslehi
Journal: Cardiovasc Res Date: 2019-04-15 Impact factor: 10.787

4. Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer.

Authors: Xiaopin Duan; Christina Chan; Nining Guo; Wenbo Han; Ralph R Weichselbaum; Wenbin Lin
Journal: J Am Chem Soc Date: 2016-12-15 Impact factor: 15.419

Review 5. Biomimetic Nanotechnology toward Personalized Vaccines.

Authors: Jiarong Zhou; Ashley V Kroll; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal: Adv Mater Date: 2019-06-17 Impact factor: 30.849

Review 6. Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.

Authors: Samaresh Sau; Hashem O Alsaab; Ketki Bhise; Rami Alzhrani; Ghazal Nabil; Arun K Iyer
Journal: J Control Release Date: 2018-01-31 Impact factor: 9.776

7. TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy.

Authors: Padmini Jayaraman; Falguni Parikh; Jared M Newton; Aurelie Hanoteau; Charlotte Rivas; Rosemarie Krupar; Kimal Rajapakshe; Ravi Pathak; Kavin Kanthaswamy; Cassie MacLaren; Shixia Huang; Cristian Coarfa; Chad Spanos; Dean P Edwards; Robin Parihar; Andrew G Sikora
Journal: Oncoimmunology Date: 2018-07-26 Impact factor: 8.110

The immune checkpoint inhibitors: where are we now?